tiprankstipranks
Eupraxia Pharmaceuticals (TSE:EPRX)
TSX:EPRX
Canadian Market
EPRX
Eupraxia Pharmaceuticals
RESEARCH TOOLSreports

Eupraxia Pharmaceuticals (EPRX) Stock News & Sentiment

63 Followers
Eupraxia Pharmaceuticals: Underdiagnosed EoE Market Expands Upside, Supporting Buy Rating on EPRX
Premium
Ratings
Eupraxia Pharmaceuticals: Underdiagnosed EoE Market Expands Upside, Supporting Buy Rating on EPRX
18d ago
EPRX
Eupraxia: Differentiated Once-Yearly EoE Therapy and Platform Expansion Support Buy Rating
Premium
Ratings
Eupraxia: Differentiated Once-Yearly EoE Therapy and Platform Expansion Support Buy Rating
20d ago
EPRX
Eupraxia Pharmaceuticals: Durable EP-104GI Data and Upcoming Catalysts Support Buy Rating
Premium
Ratings
Eupraxia Pharmaceuticals: Durable EP-104GI Data and Upcoming Catalysts Support Buy Rating
25d ago
EPRX
Eupraxia Pharmaceuticals Posts Strong Six-Month EoE Data for EP-104GI as RESOLVE Trial Advances
Premium
Company Announcements
Eupraxia Pharmaceuticals Posts Strong Six-Month EoE Data for EP-104GI as RESOLVE Trial Advances
26d ago
6K
EPRX
Buy Rating on Eupraxia Pharmaceuticals Driven by EP-104GI’s Differentiated Technology and Favorable Risk‑Reward Profile
Premium
Ratings
Buy Rating on Eupraxia Pharmaceuticals Driven by EP-104GI’s Differentiated Technology and Favorable Risk‑Reward Profile
26d ago
EPRX
Eupraxia (EPRX): Robust Cash Runway and Promising EP-104GI GI Pipeline Create Attractive Risk‑Reward and Support Buy Rating
Premium
Ratings
Eupraxia (EPRX): Robust Cash Runway and Promising EP-104GI GI Pipeline Create Attractive Risk‑Reward and Support Buy Rating
26d ago
EPRX
Eupraxia Widens Q4 Loss but Extends Cash Runway With $63 Million Financing
Premium
Company Announcements
Eupraxia Widens Q4 Loss but Extends Cash Runway With $63 Million Financing
1M ago
EPRX
More TSE:EPRX News >

EPRX News on the Web

New Strong Sell Stocks for April 2nd
Zacks
Bearish
Eupraxia Pharmaceuticals (EPRX) Receives a Buy from Cantor Fitzgerald
TipRanks News
Bullish
Eupraxia Pharmaceuticals: Underdiagnosed EoE Market Expands Upside, Supporting Buy Rating on EPRX
TipRanks News
Bullish
Eupraxia Pharmaceuticals initiated with an Outperform at William Blair
TipRanks News
Bullish
Eupraxia: Differentiated Once-Yearly EoE Therapy and Platform Expansion Support Buy Rating
TipRanks News
Bullish
Eupraxia Pharmaceuticals (EPRX) Receives a Rating Update from a Top Analyst
TipRanks News
Bullish
Eupraxia Pharmaceuticals: Durable EP-104GI Data and Upcoming Catalysts Support Buy Rating
TipRanks News
Bullish
Eupraxia Pharmaceuticals Stock Surges on Drug Trial Win
TipRanks News
Bullish

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is TSE:EPRX’s Media Buzz Sentiment?
Currently, no data Available
What is TSE:EPRX’s weekly average amount of articles?
Currently, no data Available
What is TSE:EPRX’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
AORTArtivion
NBIXNeurocrine
STAAStaar Surgical
SLPSimulations Plus
OWLTOwlet
Showing the stocks with the most bullish news sentiment over the past week